share_log

【日信证券】东宝生物调研简报:明胶稳定增长,胶原蛋白蓄势待发

日信證券 ·  Dec 27, 2011 00:00  · Researches

Profit Forecast and Rating We expect gelatin to grow by 12.00%, 13.5%, and 13.00% between 2011 and 2013, collagen by 25.78%, 160.00%, and 80.00% in 2011-2013, and the company's EPS for 2011-2013 at 0.30, 0.49, and 0.62 yuan. The price-earnings ratio for 2011-2013 corresponding to the current stock price is 60.07, 36.78, and 29.06 times, respectively. The company's profit is expected to grow rapidly in the past two years, giving the company a recommended rating.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment